3 unknown. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
Follow Yan Bi: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study. Dorzagliatin, Gliclazide - Diabetic Nephropathy Type 2 | Not applicable | Unknown | Yan Bi | 106 | 2024-02-20 | 2024-01-24 |
| Cognitive Assessment and Brain Function Evaluation in Patients With Non-alcoholic Fatty Liver Disease Cognitive assessment, functional magnetic resonance imaging - Non-Alcoholic Fatty Liver Disease, Cognitive Impairment | Unknown | Yan Bi | 500 | 2020-05-01 | 2024-06-21 | |
| Metabolic Subtypes of Non-Alcoholic Fatty Liver Disease 10-year ASCVD risk estimation - Non-Alcoholic Fatty Liver Disease, Machine Learning | Unknown | Yan Bi | 1000 | 2016-01-05 | 2024-06-21 |
Non-alcoholic Fatty Liver Disease (2) · Cognitive Dysfunction (1)
Dorzagliatin (1) · Gliclazide (1)
China (3)